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The posslblhty that mosltol 1.4,5-tnsphosphate (IPJ may act as a Ca Z+-moblhzmg second messenger m car- 
diac muscle m a manner analogous to Its actions m other cell types has been examined usmg saponm-per- 
meablhzed myocytes and isolated cardiac sarcoplasmlc reticulum Myocytes permeablhzed m the presence 
of MgATP2- sequestered Ca 2+ to a level of about 200 nM, slmllar to the cytosohc free Ca”+ concentration 
of intact cells, but addition of IP, was ineffective m causmg Ca2+ release from intracellular stores Similarly. 
IP, (up to 50 PM) was unable to mhlblt Ca2+ uptake or cause Ca2+ release from Isolated cdmne cardiac 
sarcoplasmlc reticulum vesicles m the presence of either EGTA or sodmm vanadate These results indicate 
that IP, IS unlikely to mediate moblhzatlon of mtracellular Ca2+ stores m myocardidl cells 
CaZ+ uptake Ca=+release Cardiac myocyte 
1. INTRODUCTION 
An Increased rate of hydrolysis of phosphatr- 
dyhnosttol4,5-brsphosphate has been shown to be 
Induced by a variety of hormones or sttmuh that 
increase the cytosohc free Ca’+ concentration in a 
large number of different cell types (reviews [ 1,2]). 
Recent experiments have shown that one of the 
products of phosphatrdyhnosrtol4,5brsphosphate 
hydrolysis, mosrtol 1,4,5trtsphosphate (IP3), is 
able to release Ca2+ from a non-mttochondrral, 
ATP-dependent, intracellular calcium store in 
permeabihzed hepatocytes and pancreatic acmar 
cells and to release Ca2+ from membrane vesicles 
derived from rat msulmoma endoplasmtc 
retrculum, suggesting that IP3 may act as a second 
messenger m the hormonal mobrhzatron of m- 
tracellular Ca2+ [3-71. 
Cardiac myocyte contraction is regulated by 
changes in the cytosohc free Ca2+ concentratron, 
+ To whom reprint requests should be sent 
Abbrewatron. IPs, myo-mosltol 1,4,5-trlsphosphate 
Sarcoplasmrc reticulum Inosltol 1,4,5-trlsphoyphate 
which, m turn, IS controlled by sequestration and 
release of Ca2+ by the sarcoplasmtc reticulum. It 
has been reported that admuustratton of IP3 to 
skinned frog skeletal muscle fibers elicited contrac- 
tions, suggestmg that It may be involved m 
excttatton-contractron couplmg by release of Ca2+ 
from the sarcoplasmtc reticulum [8]. cur-Adren- 
ergtc sttmulatton has been shown to have posmve 
motroprc effects m heart [9,10] and to stimulate 
phosphomosttrde turnover m isolated myocytes 
[I 1,121 Consequently, it was of interest to m- 
vestigate whether IP3 could act as a 
Ca’+-mobihzmg agent m permeabthzed myocytes. 
We report here that Ca2+ was ineffective m 
eliciting Ca2+ release with this system, and m con- 
trast to the fmdmgs of Huata et al. [13] we have 
been unable to demonstrate any effect of IP, on 
Ca2+ uptake or release by Isolated cardtac sar- 
coplasmic reticulum vestcles. 
2. MATERIALS AND METHODS 
Calcmm-tolerant myocytes were prepared from 
male, Sprague-Dawley rats (250-300 g) as de- 
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scribed [14]. The cells were washed with Ca’+-free 
Krebs bicarbonate medmm and stored with ox- 
ygenation at a concentratron of about 40 mg dry 
wt/ml. The myocytes were diluted mto medium at 
pH 7.2 and 37°C containing 110 mM KCl, 10 mM 
NaCl, 1 mM KHzPOd, 5 mM KHC03, 0.3 mM 
MgC12, 5 mM succmate, 3 lg/ml each of rotenone 
and ohgomycm, 20 mM Hepes, 0.2% (w/v) bovine 
serum albumin, 3 mM MgATp2-, 20 mM creatme 
phosphate, 20 @g/ml of creatme phosphokmase 
and 75 PM qum2. The cells (3 mg dry wt/ml) were 
permeabrhzed by addition of 45 pg/ml of saponm 
and changes m qum2-Ca2+ fluorescence were 
measured using a filter fluorometer constructed by 
the Bromedrcal Instrumentation Group (University 
of Pennsylvania) with excrtatron at 339 nm and 
emrssron at 490-570 nm as described m [5]. The 
free Ca2+ concentratron m the medium was 
calculated using a qum2-Ca2+ drssocratron con- 
stant of 115 nM [15]. 
Cardiac sarcoplasmrc reticulum was prepared as 
m [16] Oxalate supported Ca2+ uptake and Ca2+ 
release from cardiac sarcoplasmrc reticulum were 
measured by filtration assay (45Ca2+) at a free Ca2+ 
concentratron of 1 5 PM or by changes m arsenazo 
III spectral absorbance as described by Movsesran 
et al. [16,17]. Ca’+-ATPase activity was assayed 
under similar condrtrons following the method of 
Pollard and Korn [18] Ca2+-independent ATPase 
activity was measured m the presence of 2.5 mM 
excess EGTA relative to Ca2+, and Ca2+-ATPase 
activity was determined by subtracting the 
Ca2+-independent from the total ATPase activity. 
Free Ca2+ concentratrons were calculated accord- 
mg to a computer program based upon that 
published by Perrm and Sayce [19] using dlssocra- 
tlon constants reported by Fabrato and Fabrato 
[20] and Scarpa [21]. IP3 was prepared from 
human erythrocytes by the method of Downes et 
al. [22] and was also obtained as a gift from Dr B 
Agranoff (University of Michigan) using the 
method of Agranoff and Segum [23]. 
3 RESULTS 
The effect of IP3 on free Ca2+ concentrations in 
saponm-permeabrhzed myocytes was examined us- 
mg qum2 as a fluorescent Ca2+ mdrcator (frg.1) 
Permeabrhzatron of the cells m the presence of 
MgATP2- resulted m removal of Ca2+ from the 
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Frg.1 Lack of IP3 effect on Ca2+ release from sapomn- 
permeabrhzed myocytes. Myocytes were suspended m a 
concentratron of 3 mg dry wt/ml m the medium 
described in sectron 2 and Ca2+ changes were assayed 
with qum2 Myocytes were permeabrhzed (as verrfred by 
trypan blue starrung) by addmon of 45pg/ml of 
saponin, followmg which sequestration of Ca2+ 
occurred (trace a) Trabe b shows the effect of IP3 
addmon m the same medrum from which myocytes had 
been omitted A similar lack of effect of IP3 addrtron 
was obtained when Ca’+ was monitored wrth a Ca2+ 
electrode 
medium down to approx. 180 nM. The subsequent 
addition of IP3 (1.5 PM) resulted in a small 
(20 nM) increase m the free Ca2+ concentration, 
which could be reproduced by a second similar ad- 
dition to the permeabrhzed cells (fig la) or to m- 
cubation medium m the absence of cells (frg.lb). 
These results indicate that the increase m the am- 
blent free Ca2+ concentratron does not represent a 
release of Ca2+ from an intracellular storage site 
but is attributable to an artifact of IP3 addition. 
Addrtrons of glucose and hexokmase to remove 
ATP (frg la) or the Ca2+ ronophore ionomycm 
(not shown) were effective in causing Ca2+ release, 
showing that the permeabrhzed myocytes con- 
tamed mtracellular sequestered calcmm. Calcium 
from this pool could be partially released by 
20 mM caffeine but was not affected by addition 
of 1 mM sodium vanadate to mhrbrt Ca2+-ATPase 
activity (not shown) 
Further confirmation that II’3 was unable to 
release Ca2+ from intracellular stores m cardiac 
myocytes was obtained by studying the effect of 
IP3 on Ca2’ uptake and release in purrfred cardiac 
sarcoplasmic reticulum vesicles. At concentrations 
as high as 50 PM, IP3 had no effect upon Ca2+ up- 
take m cardiac sarcoplasmrc reticulum as deter- 
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Fig 2. Effect of IP3 on 4sCa2+ release by cardiac 
sarcoplasmlc reticulum Sarcoplasmlc reticulum vesicles 
were loaded with 45Ca2+ m the presence of 5 mM MgC12, 
6 mM NaN3, 5 mM NaF, 0.6 mM 45Caz+, 0 8 mM 
EGTA, 5 mM oxahc acid, 0 12 M KCl, and 40 mM 
Mops (pH 6.8, 27’C) for 5 mm (open symbols) or 
30 mm (closed symbols). Ca2’ uptake was stopped by 
add&on of EGTA (2 5 mM m excess of 45CaCIz), 
foIlowIng which IP3 was immediately added 
Intraveslcular 45Ca2+ was determmed at l-mm intervals 
m the absence (0, l ) or presence of 2.5 PM (A , A), or 
50,~M (0, m) IP3 No difference was noted when 
uptake was stopped by the addltlon of 5 mM Na3V04 
rather than EGTA (not shown) 
- 
Fig 3 Effect of IP3 on Ca” uptake and release m 
cardiac sarcoplasmlc reticulum CaCl2 was added to a 
final total concentration of 40yM to a solution 
containing 5 mM MgClz, 5 mM oxalic acid, 5 mM NaF, 
6 mM NaN3, 0.12 M KCI, 60pM arsenazo III, and 
40 mM Mops (pH 6.8, 28’C) The free CaZf 
concentration was calculated to be 5 2 FM Ca2+ uptake 
was Initiated by the addltlon of canme cardiac 
sarcoplasmic reticulum (CSSR) to a fmal concentration 
of 0 11 mg/ml When Ca2+ uptake was complete, IP3 
was added to a fmal concentration of 50&M (A) 
Followmg addltlon of IP3, CaCl2 was again added to 
augment the total concentration by 40pM, followmg 
which A23187 was added to a fmal concentration of 
IOpM This experiment was repeated m the same 
manner save for the addltlon of 5 mM Na3V04 prior to 
addltlon of IP3 (B), Na3V04 blocked by Ca2+ uptake but 
had no effect upon Ca2+ release. As a control, the 
effects of the varying additions on arsenazo III 
absorbance m a reaction mixture from which canine 
sarcoplasmlc reticulum had been omitted are shown (C) 
mined by filtration assay. Simrlarly, no release of 
45Ca2+ was observed when IP3 was added to car- 
diac sarcoplasmrc retrculum that had been loaded 
with 45Ca2+ m the presence of oxalate with Ca2+ 
uptake subsequently termmated by the addmon of 
EGTA (frg.2) Loadmg the vesrcles to a hrgher 
45Ca2+ content did not overcome thus unrespon- 
stveness to fP3. Because Ca2+ release from cardrac 
sarcoplasmlc reticulum may be Ca2+ mediated, we 
repeated this experiment using sodium vanadate m 
place of EGTA as an inhrbrtor of Ca’+ uptake. 
Ca2+ uptake and Ca2+-ATPase actrvtty were m- 
hibited half-maximally at 0.1 and 0 026 mM 
sodmm vanadate, respectrvely. In the presence of 
5 mM vanadate, however, IP3 remained unable to 
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release Cat+. It may be noted that use of stmrlar 
techniques with endoplasmic reticulum micro- 
somes derived from Syrian hamster insulinoma 
cells showed a large and maximal release of Ca2+ 
wtth 0.5 PM IP3 ([7] and unpublished). 
As the filtration assay measures mtravesicular 
Ca2’ content, the possibility cannot be discounted 
that IP3 rekaSeS Ca2+ in amounts insufficient to 
cause a measurable change m the mtravesicular 
Ca2+ content but sufficient to cause a srgmftcant 
increase in the extravesicular Ca2+ concentratron. 
This possibthty seemed particularly important in 
view of the high calcium content of the cardiac sar- 
coplasmic reticulum vesicles. For this reason, the 
effect of IPs upon Ca2+ uptake and release was ex- 
amined using arsenazo III as a spectrophotometric 
indicator of the extravesicular Ca2* concentration 
(fig.3). Addition of 50 ,NM IP3 was again shown to 
have no effect on the release of Ca2+ from sar- 
coplasmic reticulum m either the absence (fig.3A) 
or presence (ftg.3B) of sodium vanadate. Addition 
of the Ca2’ lonophore A23187, however, resulted 
in a release of Ca2+ from the calcium oxalate- 
loaded sarcoplasmic reticulum vesicles. In this 
system, addition of SO fcM IP3 to medium m the 
absence of sarcoplasmic reticulum caused a 
neghgrble addition artifact (ftg.3C). 
4. DISCUSSION 
The ability of externally added IP3 to cause CaZt 
release from a non-mrtochondnal pool of se- 
questered calcium after permeabilizatton of the 
plasma membrane IS a property exhtbtted by many 
cell types and has been demonstrated m 
hepatocytes [4,5], pancreatic acmar cells [3], GH3 
pituitary cells [24], msulinoma cells 17,251, 
neutrophlls [26], macrophages [ 131, Swiss 3T3 cells 
[27], platelets [28], and smooth muscle cells 
[29,30]. In each of these tissues spectfrc agonists 
have been shown to cause an increased rate of 
hydrolysis of phosphatrdylmositol 4,5-brsphos- 
phate and formation of mositol trrsphosphate [l]. 
Furthermore, in most of these cells the agonist has 
been shown to produce a characteristic increase of 
cytosolic free Ca” m association with the 
divergent functional response of the ttssues. These 
data, therefore, have been interpreted as 
demonstrating a second messenger role for II’3 in 
releasing mtracellular Ca2+ by activation of a 
specific Cat+ conductance in membranes of the en- 
doplasmic reticular system [I ,2]. It would perhaps 
be surprising for cardiac muscle, which has well 
developed voltage-sensitive Ca2+ channels m the 
plasma membrane [3 11, to use a similar mechanism 
for the release of activator calcium. Studies with 
quln2-loaded myocytes have in fact shown no 
response of the cytosolic free Ca2+ to 
phenylephrme or methoxamme when these agents 
were added to resting cells, although an electrical 
depolarization-dependent Ca2+ transient was 
readily observed [32]. Furthermore, the effect of 
a,-adrenergic agents on the height of the stimulus- 
induced Ca2+ transient was negligible compared 
with the effect of ,&adrenergrc agents and BAY 
k 8644 ([32] and M. Selak and J.R. Williamson, 
unpublished). 
The present studies demonstrating a lack of ef- 
fect of IP3 in causing Ca2+ release from 
permeabilized myocytes and isolated sarcoplasmrc 
reticulum suggests that cardtac muscle cells may 
lack the putative IP3 receptor m the sarcoplasmrc 
reticulum that m other cells regulates Ca2+ efflux. 
It should also be pointed out that although 
uut-adrenergic stimulatton increases the hydrolysis 
and turnover of phosphatidylinositol in cardtac 
muscle [11,12] there is no evidence that IP3 is 
formed, suggestmg that phosphohpase C has a 
preferential specificity for phosphatidylinositoi 
compared with the phosphatidyltnos~tol poly- 
phosphates in this tissue. Hormone-stimulated 
phosphatidylinositol hydrolysis may be mvolved rn 
the regulation of cardiac contractility through 
other mechanisms. The diacylglycerol product of 
phosphatidylinosttol hydrolysis may exert srgnal- 
ling mechanisms that indirectly affect 
Ca2+-transport processes through activation of 
protein kmase C [33]. For instance, a protein 
kmase C-mediated phosphorylatlon of phos- 
pholamban accompamed by a stimulation of CaZ+ 
sequestration by cardiac sarcoplasmrc reticulum 
has been demonstrated [17]. The phystologtcal 
significance of protein kinase C-mediated 
phosphorylatron of phospholamban is unclear, 
however, since pretreatment of isolated myocytes 
with up to 100 nglml of phorbol myristate acetate 
failed to increase the rate of decline of the Ca2+ 
transient induced by electrical depolarrzation m 
qum2-loaded cells (M. Selak and J.R. Wilhamson, 
unpublished). These results suggest a lack of effect 
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of protem kmase C-mediated protein phosphoryla- 
ttons on Ca2+ sequestratron by the sarcoplasmrc 
rettculum durmg the Ca2+-acttvated contractron- 
relaxatron cycle, but further studies writ be 
necessary with intact heart preparations to assess 
whether diacy~glycerol productIon through 
enhanced mosttol phosphohptd metabohsm has 
physiologtcally relevant effects on myocardtal con- 
tracttluy. Our results mdtcate that IP3 has httle, tf 
any, role m this process. 
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